New study aims to improve cervical cancer detection in HIV-Positive women
NCT ID NCT06002126
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares different HPV tests to find the best way to screen for cervical cancer in women living with HIV in Latin America. Over 1,000 participants will provide cervical, vaginal, and urine samples, plus undergo colposcopy and biopsies. The goal is to identify which test most accurately detects precancerous lesions, enabling same-day diagnosis and treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Xpert HPV test
What this could lead to
If successful, this could identify the most accurate and practical HPV testing method to prevent cervical cancer in women with HIV.
What could go wrong
This is an observational diagnostic study, not a treatment trial. Results may not apply to all populations or settings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institute of Public Health, Mexico
Cuernavaca, Morelos, 62209, Mexico
-
University of São Paulo
São Paulo, São Paulo, 05403-911, Brazil